Modulation of human lymphocyte proliferative response with aging

Area of Science:

• Immunology
• Gerontology
• Cellular Signaling

Background:

• Aging is associated with declining immune function, particularly reduced lymphocyte proliferation.
• Transmembrane signaling pathways in lymphocytes are altered with age, impacting immune responses.

Purpose of the Study:

• To investigate the efficacy of various agents in restoring age-associated decreases in lymphocyte proliferation.
• To explore interventions targeting transmembrane signaling, plasma membrane composition, and antioxidant pathways.

Main Methods:

• Assessed lymphocyte proliferation in young and old adults stimulated with mitogens (PHA, IL-2, anti-CD3 mAb).
• Tested modulatory effects of pertussis toxin, cholera toxin, isoproterenol, PMA, Ca ionophore A23187, methyl-beta-cyclodextrin (MBCD), Vitamin E, and Vitamin C.
• Analyzed MAPK ERK and p38 activation in T cells.

Main Results:

• Lymphocyte proliferative responses were significantly lower in the elderly compared to young adults.
• None of the tested agents fully restored the proliferative capacity of aged lymphocytes to young levels.
• Methyl-beta-cyclodextrin (MBCD) partially increased proliferation in the elderly, while Vitamin E inhibited responses, except when combined with MBCD.
• MAPK ERK and p38 activation decreased with age and were inhibited by Vitamin E.

Conclusions:

• Age-associated decline in lymphocyte proliferation is complex and not fully reversible with current interventions.
• Modulating lymphocyte membrane cholesterol content (e.g., with MBCD) shows potential for immunomodulation in aging.
• Targeting specific signaling molecules and membrane properties may offer future therapeutic strategies for immune aging.